We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
(+27%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$99.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$98.7M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$96.7M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$90.3M |
| 5 |
RTX Corp
RTX
|
+$82.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$122M |
| 2 |
Alibaba
BABA
|
+$107M |
| 3 |
Quest Diagnostics
DGX
|
+$107M |
| 4 |
Pfizer
PFE
|
+$88.9M |
| 5 |
Walt Disney
DIS
|
+$88.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.95% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Vulcan Materials
VMC
$35.2B
| $10.5M | 0.04% |
91,037
-25,569
| -22% | -$2.8M |
|
|
CIT
427
DELISTED
CIT Group Inc.
CIT
| $10.5M | 0.04% |
508,338
+8,200
| +2% | +$158K |
|
428
Hamilton Lane
HLNE
$3.89B
| $10.5M | 0.04% |
155,467
-66,309
| -30% | -$4.18M |
|
429
Brown-Forman Class B
BF.B
$13.2B
| $10.3M | 0.04% |
162,036
-8,283
| -5% | -$528K |
|
430
Arch Capital
ACGL
$34.5B
| $10.3M | 0.04% |
358,583
-5,400
| -1% | -$149K |
|
431
Golub Capital BDC
GBDC
$3.34B
| $10.3M | 0.04% |
880,698
+97,367
| +12% | +$1.1M |
|
432
Qualys
QLYS
$4.99B
| $10.2M | 0.04% |
+98,316
| New | +$10.3M |
|
433
Victory Capital Holdings
VCTR
$6.16B
| $10.2M | 0.04% |
592,493
+1,946
| +0.3% | +$30.5K |
|
434
Williams-Sonoma
WSM
$27.5B
| $9.96M | 0.03% |
242,854
-137,596
| -36% | -$4.68M |
|
435
AMN Healthcare
AMN
$1.35B
| $9.88M | 0.03% |
218,384
+78,386
| +56% | +$3.75M |
|
436
Moelis & Co
MC
$5.08B
| $9.67M | 0.03% |
310,475
+4,973
| +2% | +$156K |
|
437
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| $9.54M | 0.03% |
192,433
-14,671
| -7% | -$621K |
|
438
Camden National
CAC
$977M
| $9.53M | 0.03% |
275,821
+56,136
| +26% | +$1.77M |
|
439
eHealth
EHTH
$43.8M
| $9.43M | 0.03% |
95,959
-642,928
| -87% | -$74.7M |
|
440
Papa John's
PZZA
$995M
| $9.37M | 0.03% |
118,049
-47,794
| -29% | -$3.56M |
|
|
CXO
441
DELISTED
CONCHO RESOURCES INC.
CXO
| $9.27M | 0.03% |
180,055
-2,100
| -1% | -$116K |
|
|
RDS.A
442
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $9.1M | 0.03% |
278,387
-30,945
| -10% | -$1.06M |
|
443
CAE Inc. Common Shares
CAE
$8.31B
| $9.09M | 0.03% |
561,682
+240,212
| +75% | +$3.72M |
|
444
PetMed Express
PETS
$42.3M
| $9.06M | 0.03% |
+254,296
| New | +$8.83M |
|
445
Cognex
CGNX
$10.4B
| $8.96M | 0.03% |
+149,959
| New | +$8.14M |
|
446
BioMarin Pharmaceuticals
BMRN
$11.7B
| $8.9M | 0.03% |
72,154
+9,763
| +16% | +$970K |
|
447
Lattice Semiconductor
LSCC
$17.7B
| $8.82M | 0.03% |
+310,795
| New | +$7.26M |
|
448
Teleflex
TFX
$5.86B
| $8.64M | 0.03% |
23,744
-10,712
| -31% | -$3.7M |
|
449
SPX Corp
SPXC
$9.98B
| $8.6M | 0.03% |
208,911
-110,282
| -35% | -$4.15M |
|
450
Black Hills Corp
BKH
$5.5B
| $8.52M | 0.03% |
150,402
+60,400
| +67% | +$3.65M |
|
Similar funds
Lord, Abbett & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.
- Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
- Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
- Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
- Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
- Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
- Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
- Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.
Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.